Sodium monofluorophosphate was first described in 1929 by the German chemist
Willy Lange, who was then with the University of Berlin. His fruitless attempts to prepare free
monofluorophosphoric acid led him to look at the acid's
esters. Together with
Gerda von Krüger, one of his students, Lange thus synthesized
diethyl fluorophosphate which proved to be quite toxic, being the first ever
nerve agent. In the 1930s,
Gerhard Schrader, working for the German company
IG Farben, tried to develop synthetic
insecticide. His work focused on esters of phosphoric acids and resulted in the discovery of
Isoflurophate,
Tabun,
Soman, and
Sarin. In the meantime, Lange, who was married to a Jewish woman, emigrated from Germany to the United States and started work for
Procter and Gamble Company. In 1947, he and Ralph Livingston of
Monsanto Company published the preparation of the free fluorophosphoric acids and mentioned the use of
isoflurophate in the treatment of
glaucoma and
myasthenia gravis. The well known toxicity of these esters led to fears that the simple salts might also be toxic, and such fears precluded any large scale commercial use of the salts. In 1950, under sponsorship of the manufacturer of the compounds,
Ozark Chemical Company, the toxicity of sodium monofluorophosphate was studied by
Harold Hodge at the
University of Rochester who included anti-cavity testing. In 1967
Colgate-Palmolive filed several patents on the use of sodium monofluorophosphate in toothpaste. ==Safety==